Publications by authors named "Everett E Vokes"

100Publications

Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.

Oncologist 2020 Aug 30. Epub 2020 Aug 30.

Section of Hematology-Oncology, The University of Chicago Medical Center, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2020-0303DOI Listing
August 2020

Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay.

J Thorac Oncol 2020 08 27;15(8):1306-1316. Epub 2020 Apr 27.

Department of Pathology, Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2020.04.013DOI Listing
August 2020

Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes.

Int J Radiat Oncol Biol Phys 2020 Jul 18;107(4):662-671. Epub 2020 Apr 18.

Department of Radiation and Cellular Oncology, University of Chicago Medicine, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2020.04.014DOI Listing
July 2020

Prolonging Life, but at What Price?

JAMA Otolaryngol Head Neck Surg 2019 Oct 10. Epub 2019 Oct 10.

Comprehensive Cancer Center, Biological Sciences Division, Department of Medicine, University of Chicago Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoto.2019.2855DOI Listing
October 2019

Immune subgroups and the tumor microenvironment as a potential new biomarker to assess response to immunotherapy.

Chin Clin Oncol 2019 Oct 2;8(S1):S24. Epub 2019 Sep 2.

Biological Sciences Division, University of Chicago Medicine, Chicago, IL, USA; Department of Medicine, University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.08.15DOI Listing
October 2019

Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains?

J Clin Oncol 2019 11 4;37(31):2807-2814. Epub 2019 Sep 4.

University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01981DOI Listing
November 2019

Palbociclib: a new partner for cetuximab?

Lancet Oncol 2019 09 24;20(9):1195-1196. Epub 2019 Jul 24.

Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, The University of Chicago, Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045193048
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(19)30484-XDOI Listing
September 2019

Clinical prognostic model for older patients with advanced non-small cell lung cancer.

J Geriatr Oncol 2019 07 21;10(4):555-559. Epub 2019 Feb 21.

Duke University Medical Center, Durham, NC, USA; Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18794068183019
Publisher Site
http://dx.doi.org/10.1016/j.jgo.2019.02.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136030PMC
July 2019

Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer.

J Thorac Oncol 2019 02 4;14(2):298-303. Epub 2018 Oct 4.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina; Alliance Statistics and Data Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.09.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348032PMC
February 2019

Management of Early Head and Neck Cancer in Elderly Patients.

J Oncol Pract 2018 09;14(9):541-546

University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00078
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00078DOI Listing
September 2018

Heuristic value-based framework for lung cancer decision-making.

Oncotarget 2018 Jul 6;9(52):29877-29891. Epub 2018 Jul 6.

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057456PMC
July 2018

The Impact of Staging by Positron-Emission Tomography on Overall Survival and Progression-Free Survival in Patients With Locally Advanced NSCLC.

J Thorac Oncol 2018 08 5;13(8):1183-1188. Epub 2018 May 5.

Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.028DOI Listing
August 2018

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients.

Oncotarget 2018 Apr 13;9(28):19793-19806. Epub 2018 Apr 13.

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929426PMC
April 2018

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience.

Oral Oncol 2018 05 16;80:16-22. Epub 2018 Mar 16.

Department of Radiation and Cellular Oncology, University of Chicago, 5758 S. Maryland Avenue, M/C 9006, Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2018.03.008DOI Listing
May 2018

Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC.

J Thorac Oncol 2018 08 22;13(8):1171-1182. Epub 2018 Apr 22.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina; Alliance Statistics and Data Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.011DOI Listing
August 2018

Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.

Clin Lung Cancer 2018 05 5;19(3):230-238.e2. Epub 2017 Dec 5.

Department of Medicine, University of Chicago Medicine and Biological Sciences, Chicago, IL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.11.010DOI Listing
May 2018

ALK and ROS1 rearrangement in NSCLC: rapidly evolving standards.

Lancet Oncol 2017 12 23;18(12):1555-1556. Epub 2017 Oct 23.

Department of Medicine, University of Chicago Medicine and Biological Sciences, Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30708-8DOI Listing
December 2017

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

J Clin Oncol 2017 Dec 12;35(35):3924-3933. Epub 2017 Oct 12.

Leora Horn, Vanderbilt-Ingram Cancer Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Everett E. Vokes, University of Chicago, Chicago, IL; Esther Holgado, Hospital De Madrid, Norte Sanchinarro, Madrid; Enriqueta Felip, Hospital Universitari Vall d'Hebron, Barcelona; Luis Paz-Ares, Hospital Universitario Virgen Del Rocio, Seville, Spain; Neal Ready, Duke University Medical Center, Durham, NC; Martin Steins, Thoraxklinik-Heidelberg gGmbH, Heidelberg; Martin Kohlhäeufl, Robert-Bosch-Krankenhaus, Stuttgart; Martin Reck, LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Wilfried E.E. Eberhardt, University Hospital and Ruhrlandclinic, University of Duisburg-Essen, Essen, Germany; Elena Poddubskaya, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Adam Pluzanski, Centrum Onkologii-Instytut Im. Marii Sklodowskiej-Curie, Warsaw, Poland; Karen L. Reckamp, City of Hope, Duarte, CA; Marco A. Burgio and Lucio Crinò, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Scientifico Romagnolo Per lo Studio e la Cura dei Tumori, Meldola, Italy; David Waterhouse, Oncology Hematology Care (OHC)/US Oncology, Cincinnati, OH; Fabrice Barlesi, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Marseille; Jérôme Fayette, Léon Bérard, Lyon, France; Scott Antonia, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Oscar Arrieta, Instituto Nacional De Cancerologia, Mexico City, Mexico; Naiyer Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; William J. Geese, Ang Li, Anne Blackwood-Chirchir, and Diane Healey, Bristol-Myers Squibb, Princeton, NJ; and Julie Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.3062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075826PMC
December 2017

Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.

J Clin Oncol 2017 Sep 11;35(25):2885-2892. Epub 2017 May 11.

Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.4758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578390PMC
September 2017

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

J Clin Oncol 2017 Jul 10;35(19):2184-2192. Epub 2017 May 10.

Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Xiaofei Wang and Lydia Hodgson, Alliance Statistical and Data Center, Duke University; Thomas E. Stinchcombe, Duke University School of Medicine, Durham, NC; Richard T. Cheney, Roswell Park Cancer Institute, Buffalo; Ajeet Gajra, State University of New York Upstate Medical University, Syracuse, NY; Maria Q. Baggstrom, Washington University School of Medicine, St Louis, MO; Sachdev P. Thomas, Illinois Cancer Care, Peoria; Paula N. Friedman and Everett E. Vokes, University of Chicago; Olwen M. Hahn, Alliance Protocol Office, University of Chicago, Chicago, IL; Erin Bertino, The Ohio State University Medical Center, Columbus, OH; Karen L. Reckamp, City of Hope Comprehensive Cancer Center, Duarte, CA; Julian Molina, Mayo Clinic, Rochester; Jon Ritter, University of Minnesota, Minneapolis, MN; Joan H. Schiller, University of Texas Southwestern Medical Center, Dallas, TX; Kisha Mitchell-Richards, Yale University, New Haven, CT; and Ginger Milne, Vanderbilt University, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3743DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493050PMC
July 2017

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

N Engl J Med 2016 11 8;375(19):1856-1867. Epub 2016 Oct 8.

From the University of Pittsburgh Medical Center and Cancer Institute, Pittsburgh (R.L.F.); the Department of Thoracic-Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (G.B.); Centre Leon Berard, Lyon (J.F.), Centre Antoine Lacassagne, Nice (J.G.), and Institut Gustave Roussy, Villejuif (C.E.) - all in France; Stanford Cancer Institute, Stanford, CA (A.D.C.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan (L.L.); Institute of Cancer Research-Royal Marsden National Institute for Health Research Biomedical Research Centre, London (K.H.); University Hospital Essen, Essen, Germany (S.K.); University of Chicago, Chicago (E.E.V.); University of Michigan, Ann Arbor (F.W.); Winship Cancer Institute of Emory University, Atlanta (N.F.S.); Hospital Universitario 12 de Octubre, Madrid (L.C.I.D.); Dana-Farber Cancer Institute, Boston (R.H.); Universitätsspital Zurich, Zurich, Switzerland (T.R.); Kobe University Hospital, Kobe (N.K.), and National Cancer Center Hospital East, Kashiwa (M.T.) - both in Japan; Bristol-Myers Squibb, Princeton, NJ (M.M., M.L., W.J.G., J.K., J.W.S.); and Ohio State University, Columbus (M.L.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1602252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564292PMC
November 2016

Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.

J Clin Oncol 2016 11 30;34(33):3992-3999. Epub 2016 Sep 30.

Herbert H. Pang and Perry Cheng, School of Public Health, Li Ka Shing Faculty of Medicine, Hong Kong, Special Administrative Region, People's Republic of China; Herbert H. Pang, Xiaofei Wang, Ying Zhang, Thomas E. Stinchcombe, and Harvey J. Cohen, Duke University School of Medicine, Durham, NC; Melisa L. Wong, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco; David Gandara, University of California, Davis Comprehensive Cancer Center, Sacramento, CA; Apar Kishor Ganti, Veterans Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE; Daniel J. Sargent and Sumithra J. Mandrekar, Mayo Clinic, Rochester, MN; Chen Hu, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Chen Hu, Johns Hopkins University School of Medicine, Baltimore, MD; Mary W. Redman, Fred Hutchinson Cancer Research Center, Seattle, WA; Judith B. Manola, Dana-Farber Cancer Institute, Boston, MA; Richard L. Schilsky, ASCO, Alexandria, VA; Jeffrey D. Bradley, Washington University School of Medicine, St Louis, MO; Alex A. Adjei, Roswell Park Cancer Institute, Buffalo, NY; Suresh S. Ramalingam, The Winship Cancer Institute of Emory University, Atlanta, GA; and Everett E. Vokes, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.7088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477832PMC
November 2016

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.

Clin Lung Cancer 2017 01 27;18(1):5-12. Epub 2016 Jun 27.

Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.06.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361177PMC
January 2017

HPV-Associated Head and Neck Cancer.

J Natl Cancer Inst 2015 Dec 9;107(12):djv344. Epub 2015 Dec 9.

Section of Hematology-Oncology, Department of Medicine (EEV, TYS), Section of Otolaryngology and Head and Neck Surgery, Department of Surgery (NA), and The University of Chicago Comprehensive Cancer Center (EEV, TYS), The University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470204510
Web Search
https://www.researchgate.net/profile/Adam_Kimple/publication
Web Search
http://jnci.oxfordjournals.org/content/107/12/djv344.full.pd
Web Search
http://dx.doi.org/10.1093/jnci/djv344DOI Listing
December 2015

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Oct 27;373(17):1627-39. Epub 2015 Sep 27.

From the Fox Chase Cancer Center, Philadelphia (H.B.); Hospital Universitario Virgen del Rocio, Seville (L.P.-A.), Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (E.F.), and Hospital de Madrid, Norte Sanchinarro, Madrid (E.H.) - all in Spain; Vanderbilt-Ingram Cancer Center (L.H.), and Sarah Cannon Research Institute and Tennessee Oncology (D.R.S.) - both in Nashville; Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.) and Robert-Bosch-Krankenhaus Stuttgart, Gerlingen (M.K.) - both in Germany; Duke University Medical Center, Durham, NC (N.E.R.); University of Washington, Seattle (L.Q.C.); University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Marseille (F.B.), Centre Léon Bérard, Lyon (J.F.), and Centre Hospitalier Universitaire de Rennes, Rennes (H.L.) - all in France; Instituto Nacional de Cancerologia, Mexico City (O.A.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Forlì-Cesena (M.A.B.), and Ospedale di Perugia, Perugia (L.C.) - both in Italy; N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); University of Texas Southwestern Medical Center, Dallas (D.E.G.); Yale Comprehensive Cancer Center, New Haven, CT (S.N.G.); Memorial Sloan Kettering Cancer Center, New York (C.M.R., N.R.); University of Texas M.D. Anderson Cancer Center, Houston (G.R.B.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.J.A.); Bristol-Myers Squibb, Princeton, NJ (C.D., C.T.H., F.G.F.); and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.R.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1507643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705936PMC
October 2015

Lung cancer-a fractal viewpoint.

Nat Rev Clin Oncol 2015 Nov 14;12(11):664-75. Epub 2015 Jul 14.

Section of Hematology/Oncology, University of Chicago, 5841 South Maryland Avenue, MC 2115 Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989864PMC
November 2015

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1099-106

*Division of Biomedical Statistics and Informatics, Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota; †Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona; ‡Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; §Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, North Carolina; ‖Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; ¶Department of Oncology, NCIC Clinical Trials Group, Queen' University, Kingston, ON, Canada; #Department of Hematology & Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia; **Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California; ††Department of Statistics for the Data Center/Operations Office, Japan Clinical Oncology Group Data Center, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan; ‡‡Department of Medical Oncology, Japanese Society of Medical Oncology, Tokyo, Japan; §§Department of Medicine, The University of Chicago Medicine and Biologic Sciences Center, Chicago, Illinois; and ‖‖Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153349
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493926PMC
July 2015

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer.

Sci Rep 2015 Jun 15;5:10641. Epub 2015 Jun 15.

Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep10641DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466581PMC
June 2015

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Jul 31;373(2):123-35. Epub 2015 May 31.

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.B.); the City of Hope Comprehensive Cancer Center, Duarte, CA (K.L.R.); the Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam (P.B.), Erasmus MC Cancer Institute, Rotterdam (J.G.A.), and Ziekenhuis Amphia, Breda (J.G.A.) - all in the Netherlands; the University Hospital of Perugia, Perugia (L.C.), and the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.) - both in Italy; the Department of Medical Oncology, West German Cancer Center, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen (W.E.E.E.), the Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.), and the LungenClinic Grosshansdorf, Grosshansdorf (M.R.) - all in Germany; the N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); the H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.A.); the Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland (A.P.); the University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); the Hospital Madrid Norte Sanchinarro (E.H.), the Hospital Universitario Fundación Jiménez Díaz, Madrid (M.D.), and the Hospital Universitario Virgen Del Rocío, Seville (L.P.-A.) - all in Spain; Oncology Hematology Care, Cincinnati (D.W.); the Duke University Medical Center, Durham, NC (N.R.); Massachusetts General Hospital, Boston (J.G.); Centro Internacional de Estudios Clinicos, Santiago, Chile (O.A.F.); Nemocnice Na Bulovce, Prague, Czech Republic (L.H.); Bristol-Myers Squibb, Princeton, NJ (C.B., C.T.H., B.L.); and the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681400PMC
July 2015

Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.

Cancer Epidemiol Biomarkers Prev 2015 Aug 26;24(8):1222-8. Epub 2015 May 26.

Department of Pediatrics, The University of Chicago, Chicago, Illinois. The University of Chicago Comprehensive Cancer Center, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526396PMC
August 2015

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).

J Clin Oncol 2015 May 2;33(15):1660-5. Epub 2015 Mar 2.

Neal E. Ready and Jeffrey Crawford, Duke University Medical Center; Herbert H. Pang and Lin Gu, Alliance Statistics and Data Center, Duke University Medical Center, Durham; Antonius A. Miller, Wake Forest University Medical Center, Winston Salem, NC; Gregory A. Otterson, Ohio State University Medical Center, Columbus, OH; Sachdev P. Thomas, Illinois Oncology Research Association Community Clinical Oncology Program, Illinois Cancer Care, Peoria; Everett E. Vokes, University of Chicago, Chicago, IL; Maria Baggstrom, Washington University School of Medicine, St Louis, MO; Gregory A. Masters, Christiana Healthcare Services, Christiana Hospital, Newark, DE; Stephen L. Graziano and Jeffrey Bogart, State University of New York Upstate Medical University, Syracuse, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.3105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429175PMC
May 2015

Reply to s. Chakraborty et al.

J Clin Oncol 2015 Mar 9;33(8):968. Epub 2015 Feb 9.

University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.6189DOI Listing
March 2015

EGFR-based bioradiotherapy in SCCHN.

Lancet Oncol 2015 Feb 15;16(2):129-30. Epub 2015 Jan 15.

Department of Medicine and Comprehensive Cancer Research Center, University of Chicago Medicine and Biological Sciences, 5841 S Maryland Avenue, MC2115, Chicago, IL 60637, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)70006-9DOI Listing
February 2015

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.

Clin Cancer Res 2015 Feb 9;21(4):870-81. Epub 2014 Dec 9.

Department of Medicine, The University of Chicago, Chicago, Illinois. The University of Chicago Comprehensive Cancer Center, Chicago, Illinois. Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2481DOI Listing
February 2015

Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.

Oral Oncol 2015 Jan 23;51(1):53-8. Epub 2014 Sep 23.

Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA; Institute for Genomics and Systems Biology, Chicago, IL, USA; The University of Chicago Comprehensive Cancer Research Center, Chicago, IL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2014.08.014DOI Listing
January 2015

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

J Clin Oncol 2014 Sep 21;32(25):2735-43. Epub 2014 Jul 21.

Ezra E.W. Cohen, Theodore G. Karrison, Masha Kocherginsky, Jeffrey Mueller, Robyn Egan, Tanguy Y. Seiwert, Victoria M. Villaflor, Daniel J. Haraf, and Everett E. Vokes, University of Chicago, Chicago; Bruce E. Brockstein, North Shore University Health System, Evanston; Mark B. Agulnik and Bharat B. Mittal, Northwestern University, Chicago, IL; Chao H. Huang, University of Kansas and Veterans Affairs Medical Center, Kansas City, KS; Furhan Yunus and Sandeep Samant, University of Tennessee, Memphis, TN; Luis E. Raez, University of Miami, Miami, FL; Ranee Mehra, Fox Chase Cancer Center, Philadelphia, PA; Priya Kumar and Frank Ondrey, University of Minnesota, Minneapolis, MN; and Patrice Marchand and Bettina Braegas, Nuvisan Oncology, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/07/18/JCO.2013.54
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.6309
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.6309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876357PMC
September 2014

DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.

PLoS One 2014 14;9(7):e102112. Epub 2014 Jul 14.

Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois, United States of America; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0102112PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096922PMC
November 2015

Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer.

Oral Oncol 2014 Sep 10;50(9):825-31. Epub 2014 Jul 10.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA; The University of Chicago Comprehensive Cancer Center, Chicago, IL 60627, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2014.06.004DOI Listing
September 2014

Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.

J Geriatr Oncol 2013 Oct 10;4(4):327-33. Epub 2013 Jun 10.

University of Chicago, Department of Medicine, Section of Hematology/Oncology, Chicago, IL, USA; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18794068130005
Publisher Site
http://dx.doi.org/10.1016/j.jgo.2013.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413907PMC
October 2013

CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer.

J Thorac Oncol 2014 Feb;9(2):214-21

*Department of Thoracic Oncology, Massachusetts General Hospital, Boston, Massachusetts; †Department of Oncology, Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina; ‡Department of Oncology, Ohio State University Medical Center, Columbus, Ohio; §Department of Oncology, University of North Carolina, Chapel Hill, North Carolina; ‖Department of Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; ¶Department of Oncology, Kinston Medical Specialists, P.A., Kinston, North Carolina; #Department of Oncology, University of Chicago, Chicago, Illinois; and **Department of Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284815PMC
February 2014

Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.

Mol Cancer Ther 2014 Mar 10;13(3):576-84. Epub 2013 Dec 10.

Corresponding Author: Ravi Salgia, Section of Hematology/Oncology, Department of Medicine, The University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286701PMC
March 2014

Race and competing mortality in advanced head and neck cancer.

Oral Oncol 2014 Jan 14;50(1):40-4. Epub 2013 Oct 14.

Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2013.09.012DOI Listing
January 2014

EGFR-directed treatments in SCCHN.

Lancet Oncol 2013 Jul 6;14(8):672-3. Epub 2013 Jun 6.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70215-8DOI Listing
July 2013

Non-small-cell lung cancer: then and now.

J Clin Oncol 2013 Mar 11;31(8):981-3. Epub 2013 Feb 11.

Division of Hematology-Oncology, University of Texas Southwestern, Dallas, TX 75390-8852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.5772DOI Listing
March 2013

New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.

J Clin Oncol 2013 Mar 11;31(8):1029-38. Epub 2013 Feb 11.

Duke University, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.5064DOI Listing
March 2013

Competing roads to larynx preservation.

Authors:
Everett E Vokes

J Clin Oncol 2013 Mar 22;31(7):833-5. Epub 2013 Jan 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.45.8976DOI Listing
March 2013

Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.

Oral Oncol 2012 Oct 22;48(10):1025-1030. Epub 2012 May 22.

Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, United States; Comprehensive Cancer Center, University of Chicago, Chicago, IL, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2012.04.004DOI Listing
October 2012

Differential expression of RON in small and non-small cell lung cancers.

Genes Chromosomes Cancer 2012 Sep 14;51(9):841-51. Epub 2012 May 14.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.21968DOI Listing
September 2012

Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.

Oncol Rep 2012 May 27;27(5):1625-9. Epub 2012 Jan 27.

Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2012.1666DOI Listing
May 2012

Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

Lung Cancer 2012 Jun 22;76(3):393-6. Epub 2011 Dec 22.

Department of Medicine, Division of Hematology Oncology, University of California, San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.11.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778731PMC
June 2012

MET and phosphorylated MET as potential biomarkers in lung cancer.

J Environ Pathol Toxicol Oncol 2011 ;30(4):341-54

University of Chicago, Department of Pathology, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1615/jenvironpatholtoxicoloncol.v30.i4.70DOI Listing
February 2012